Patents Assigned to INGENIA Therapeutics Inc.
  • VEGF and TIE2-Binding Fusion Protein and Uses Thereof
    Publication number: 20230287109
    Abstract: The present disclosure refers to a fusion protein having an antibody against Tie-2 or antigen-binding fragment thereof and a vascular endothelial growth factor (VEGF)-binding domain, methods for making the fusion protein, and pharmaceutical compositions and methods for preventing or treating angiogenic or vascular diseases or regulating angiogenesis, endothelial signaling, inflammation, and/or vascular leakage, which comprise the fusion protein.
    Type: Application
    Filed: January 12, 2023
    Publication date: September 14, 2023
    Applicant: INGENIA Therapeutics Inc.
    Inventors: Minkyung Choo, Kwangsoo Kim, Sangyeul Han, Philip Durost